This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by García, E. Articles by Delcán, J. L. Search for Related Content PubMed PubMed Citation Articles by García, E. Articles by Delcán, J. L.

CLINICAL STUDIES

Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction

^a Unit of Interventional Cardiology, Division of Cardiology, "Gregorio Marañón" University General Hospital, Madrid, Spain

Manuscript received March 3, 1998; revised manuscript received September 21, 1998, accepted November 2, 1998.

Reprint requests and correspondence: Dr. Eulogio García, Sección de Hemodinámica, Servicio de Cardiología, Hospital General Universitario "Gregorio Marañón", C/Doctor Esquerdo 46, 28007 Madrid, Spain

OBJECTIVES

This study compares the efficacy of primary angioplasty and systemic thrombolysis with t-PA in reducing the in-hospital mortality of patients with anterior AMI.

BACKGROUND

Controversy still exists about the relative benefit of primary angioplasty over thrombolysis as treatment for AMI.

METHODS

Two-hundred and twenty patients with anterior AMI were randomly assigned in our institution to primary angioplasty (109 patients) or systemic thrombolysis with accelerated t-PA (111 patients) within the first five hours from the onset of symptoms.

RESULTS

Baseline characteristics were similar in both groups. Primary angioplasty was independently associated with a lower in-hospital mortality (2.8% vs. 10.8%, p = 0.02, adjusted odds ratio 0.23, 95% confidence interval 0.06 to 0.85). During hospitalization, patients treated by angioplasty had a lower frequency of postinfarction angina or positive stress test (11.9% vs. 25.2%, p = 0.01) and less frequently underwent percutaneous or surgical revascularization after the initial treatment (22.0% vs. 47.7%, p < 0.001) than did patients treated by t-PA. At six month follow-up, patients treated by angioplasty had a lower cumulative rate of death (4.6% vs. 11.7%, p = 0.05) and revascularization (31.2% vs. 55.9%, p < 0.001) than those treated by t-PA.

CONCLUSIONS

In centers with an experienced and readily available interventional team, primary angioplasty is superior to t-PA for the treatment of anterior AMI.

Abbreviations and Acronyms   AMI = acute myocardial infarction   CABG = coronary artery bypass graft surgery   CK-MB = MB fraction of creatine kinase   LAD = left anterior descending coronary artery   PTCA = percutaneous transluminal coronary angioplasty   t-PA = tissue plasminogen activator

This article has been cited by other articles:

				C. J. Terkelsen and T. T. Nielsen Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: Acute Angioplasty May Be Feasible for the Majority of U.S. Citizens J. Am. Coll. Cardiol., September 9, 2008; 52(11): 966 - 967. [Full Text] [PDF]

				C. Asseburg, Y. Bravo Vergel, S. Palmer, E. Fenwick, M. de Belder, K. R Abrams, and M. Sculpher Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis Heart, October 1, 2007; 93(10): 1244 - 1250. [Abstract] [Full Text] [PDF]

				W. E. Boden, K. Eagle, and C. B. Granger Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options J. Am. Coll. Cardiol., September 4, 2007; 50(10): 917 - 929. [Abstract] [Full Text] [PDF]

				J. R. Timmer, J. P. Ottervanger, M.-J. de Boer, E. Boersma, C. L. Grines, C. M. Westerhout, R. J. Simes, C. B. Granger, F. Zijlstra, and for the Primary Coronary Angioplasty vs Thrombolys Primary Percutaneous Coronary Intervention Compared With Fibrinolysis for Myocardial Infarction in Diabetes Mellitus: Results From the Primary Coronary Angioplasty vs Thrombolysis-2 Trial Arch Intern Med, July 9, 2007; 167(13): 1353 - 1359. [Abstract] [Full Text] [PDF]

				C. S. Hollenbeak, J. P. Fitzgibbons, M. Rossi, D. L. Morris, and P. Stillman The Impact of Percutaneous Coronary Interventions on Outcomes for Acute Myocardial Infarction in Pennsylvania American Journal of Medical Quality, March 1, 2007; 22(2): 85 - 94. [Abstract] [PDF]

				H. H. Ting, E. H. Yang, and C. S. Rihal Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction. Ann Intern Med, October 17, 2006; 145(8): 610 - 617. [Abstract] [Full Text] [PDF]

				E. Boersma and The Primary Coronary Angioplasty vs. Thrombolysis Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients Eur. Heart J., April 1, 2006; 27(7): 779 - 788. [Abstract] [Full Text] [PDF]

				Part 5: Acute Coronary Syndromes Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72. [Full Text] [PDF]

				K. Huber, R. D. Caterina, S. D. Kristensen, F. W.A. Verheugt, G. Montalescot, L. B. Maestro, F. V. d. Werf, and for the Task Force on Pre-hospital Reperfusion The Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction Eur. Heart J., October 1, 2005; 26(19): 2063 - 2074. [Full Text] [PDF]

				M. R. Le May, G. A. Wells, M. Labinaz, R. F. Davies, M. Turek, D. Leddy, J. Maloney, T. McKibbin, B. Quinn, R. S. Beanlands, et al. Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study) J. Am. Coll. Cardiol., August 2, 2005; 46(3): 417 - 424. [Abstract] [Full Text] [PDF]

				Writing Committee Members, E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, et al. ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J. Am. Coll. Cardiol., August 4, 2004; 44(3): 671 - 719. [Full Text] [PDF]

				E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, G. A. Lamas, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation, August 3, 2004; 110(5): 588 - 636. [Full Text] [PDF]

				R. A. Kloner and S. H. Rezkalla Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J. Am. Coll. Cardiol., July 21, 2004; 44(2): 276 - 286. [Abstract] [Full Text] [PDF]

				D. Smith Primary angioplasty should be first line treatment for acute myocardial infarction: FOR BMJ, May 22, 2004; 328(7450): 1254 - 1256. [Full Text] [PDF]

				M. R. Le May, R. F. Davies, M. Labinaz, H. Sherrard, J.-F. Marquis, L. A. Laramee, E. R. O'Brien, W. L. Williams, R. S. Beanlands, G. Nichol, et al. Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction: Cost Analysis of the Canadian STAT Study Circulation, November 25, 2003; 108(21): 2624 - 2630. [Abstract] [Full Text] [PDF]

				J Hilden and A Gammelgaard Premature stopping and informed consent in AMI trials J. Med. Ethics, June 1, 2002; 28(3): 188 - 189. [Abstract] [Full Text] [PDF]

				F Zijlstra, A Patel, M Jones, C.L Grines, S Ellis, E Garcia, L Grinfeld, R.J Gibbons, E.E Ribeiro, F Ribichini, et al. Clinical characteristics and outcome of patients with early (<2h), intermediate (2-4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction Eur. Heart J., April 1, 2002; 23(7): 550 - 557. [Abstract] [Full Text] [PDF]

				R. Moreno, J. Lopez-Sendon, E. Garcia, L. P.e. de Isla, E. L.o. de Sa, A. Ortega, M. Moreno, R. Rubio, J. Soriano, M. Abeytua, et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction J. Am. Coll. Cardiol., February 20, 2002; 39(4): 598 - 603. [Abstract] [Full Text] [PDF]

				R. Zahn, R. Schiele, S. Schneider, A. K. Gitt, H. Wienbergen, K. Seidl, T. Voigtlander, M. Gottwik, G. Berg, E. Altmann, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty?: Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1827 - 1835. [Abstract] [Full Text] [PDF]

				F. Verdu-Pascual and A. Castello-Ponce Randomised clinical trials: a source of ethical dilemmas J. Med. Ethics, June 1, 2001; 27(3): 177 - 178. [Abstract] [Full Text] [PDF]

				M. R. Le May, M. Labinaz, R. F. Davies, J.-F. Marquis, L. A. Laramee, E. R. O'Brien, W. L. Williams, R. S. Beanlands, G. Nichol, and L. A. Higginson Stenting versus thrombolysis in acute myocardial infarction trial (STAT) J. Am. Coll. Cardiol., March 15, 2001; 37(4): 985 - 991. [Abstract] [Full Text] [PDF]

				E. L. Hannan, M. J. Racz, D. T. Arani, T. J. Ryan, G. Walford, and B. D. McCallister Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1194 - 1201. [Abstract] [Full Text] [PDF]

				T. P. Wharton Jr., N. Sinclair McNamara, F. A. Fedele, M. I. Jacobs, A. R. Gladstone, and E. J. Funk Reply J. Am. Coll. Cardiol., July 1, 2000; 36(1): 301 - 303. [Full Text] [PDF]